INTEGRA HOLDINGS
Integra Holdings is a unique venture fund that combines academic excellence, funding and R&D guidance together with a strong and proven business network — the most important elements necessary to bring academic innovation to the market. Focusing on an exclusive selection of biotech companies with proprietary solutions and a competitive advantage in their respective fields, Integra takes a hands-on approach by providing our portfolio companies the strategic planning and business development necessary to bring their technology to the market.
INTEGRA HOLDINGS
Social Links:
Industry:
Biotechnology Business Development Information Technology
Founded:
1989-01-01
Status:
Active
Email Addresses:
[email protected]
Total Funding:
28 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Font Awesome Wordpress Plugins
Similar Organizations
Atos
Atos provides consulting services and solutions, ranging from supporting strategy development to enterprise solutions and technology.
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Brighter
Data-driven solutions for smarter treatment of chronic conditions.
Molecular Health
Molecular Health offers software solutions for evidence-based healthcare decision support and smarter drug development.
Neurimmune Holding
Neurimmune develops innovative immunotherapeutics for human diseases.
OmniAb
Therapeutic antibody discovery
S2G Ventures
S2G Ventures is a multi-stage venture fund focusing on investments in food and agriculture industries.
Current Employees Featured
Investors List
Arie Capital
Arie Capital investment in Venture Round - Integra Holdings
Temasek Holdings
Temasek Holdings investment in Venture Round - Integra Holdings
Guangxi Wuzhou Pharmaceutical Group
Guangxi Wuzhou Pharmaceutical Group investment in Venture Round - Integra Holdings
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-05-13 | Splisense | Integra Holdings investment in Series B - Splisense | 28.5 M USD |
| 2018-01-01 | BacoCure | Integra Holdings investment in Seed Round - BacoCure | N/A |
| 2018-01-01 | Rebiotic Rx | Integra Holdings investment in Seed Round - Rebiotic Rx | N/A |
| 2017-12-04 | Atox Bio | Integra Holdings investment in Series F - Atox Bio | 30 M USD |
| 2017-01-01 | Nectin Therapeutics | Integra Holdings investment in Seed Round - Nectin Therapeutics | N/A |
| 2016-01-01 | Splisense | Integra Holdings investment in Seed Round - Splisense | N/A |
| 2014-01-01 | Ophrx | Integra Holdings investment in Seed Round - Ophrx | N/A |
| 2014-01-01 | NeoProl | Integra Holdings investment in Seed Round - NeoProl | N/A |